Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel

Interest in genomic testing for the selection of cancer therapy is growing. However, the cost of genomic testing has not been well studied. We sought to determine the price of identifying mutations and copy number alterations (CNAs) in theoretically actionable genes across multiple tumor types. We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Chan, Meric-Bernstam, Funda, Su, Xiaoping, Mendelsohn, John, Giordano, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342111/
https://www.ncbi.nlm.nih.gov/pubmed/27634896
http://dx.doi.org/10.18632/oncotarget.11994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342111/
https://www.ncbi.nlm.nih.gov/pubmed/27634896
http://dx.doi.org/10.18632/oncotarget.11994

Ejemplares similares